Your browser doesn't support javascript.
loading
Characterizing heart failure and its subtypes in people living with HIV.
Inestroza, Karla; Hurtado, Vanessa; Larson, Michaela E; Satish, Sanjana; Severdija, Ryan; Ebner, Bertrand; Lang, Barbara; Jones, Deborah; Alcaide, Maria; Martinez, Claudia.
Afiliación
  • Inestroza K; Cardiovascular Diseases Fellowship, Mayo Clinic College of Medicine and Sciences, Rochester, Minnesota, USA.
  • Hurtado V; Cardiovascular Diseases Fellowship, University of South Florida, Tampa, Florida, USA.
  • Larson ME; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Satish S; Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Severdija R; Internal Medicine Residency, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Ebner B; Cardiovascular Diseases Fellowship, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Lang B; Department of Medicine, Cardiovascular Division, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Jones D; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Alcaide M; Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Martinez C; Department of Medicine, Cardiovascular Division, University of Miami Miller School of Medicine, Miami, Florida, USA.
HIV Med ; 2024 Jul 30.
Article en En | MEDLINE | ID: mdl-39081068
ABSTRACT

OBJECTIVE:

People living with HIV have an increased risk of heart failure (HF). There are different subtypes of HF. Knowledge about the factors differentiating HF subtypes in people with HIV is limited but necessary to guide preventive measures and treatment.

METHODS:

A retrospective review of medical records was undertaken in people with HIV aged ≥18 years who received care at the University of Miami/Jackson Memorial HIV Clinic between January 2017 and November 2019 (N = 1166). Patients with an echocardiogram available for review (n = 305) were included. HF was defined as a documented diagnosis of any HF subtype (n = 52). We stratified those with HF by their ejection fraction (EF) into HF with preserved EF (HFpEF), HF with borderline EF, or HF with reduced EF (HFrEF).

RESULTS:

The prevalence of HF was 4.5%. The cohort included 46.2% females and 75% self-identified African Americans. Those with HF had a higher prevalence of hypertension, prior myocardial infarction, angina, coronary artery disease, percutaneous coronary intervention, coronary artery bypass grafting, diastolic dysfunction, and left ventricle hypertrophy. People with HIV with HF with borderline EF exhibited more coronary artery disease than those with HFpEF.

CONCLUSIONS:

We characterize HF in people with HIV in South Florida and report the prevalence of HF and HF subtypes. Only a small percentage of patients had echocardiograms performed, suggesting an ongoing need for recognition of the increased risk of HF in people living with HIV, and raising the concern about lack of awareness contributing to underdiagnosis and missed treatment opportunities in this population.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: HIV Med Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: HIV Med Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido